[1]
|
Rodrigues, J.C., Haas, M. and Reich, H.N. (2017) IgA Nephropathy. Clinical Journal of the American Society of Neph-rology, 12, 677-686. https://doi.org/10.2215/CJN.07420716
|
[2]
|
Pei, G., Qin, A., Dong, L., Wang, S., Liu, X., Yang, D., Tan, J., Zhou, X., Tang, Y. and Qin, W. (2022) Prognostic Value of Triglyceride to High-Density Lipoprotein Cholesterol Ratio (TG/HDL-C) in IgA Nephropathy Patients. Frontiers in Endocrinology (Lausanne), 13, Article ID: 877794. https://doi.org/10.3389/fendo.2022.877794
|
[3]
|
Nguyen, H.H., Tran, H.H., Nguyen, L.T., Nguyen, T., Nguyen, N.A., Vi, M.T. and Nguyen, K.T. (2022) TG/HDL-C Ratio Is a Risk Factor Associated with CKD: Use in As-sessing the Risk of Progression of CKD. Pathophysiology, 29, 374-382. https://doi.org/10.3390/pathophysiology29030029
|
[4]
|
Kant, S., Kronbichler, A., Sharma, P. and Geetha, D. (2022) Advances in Understanding of Pathogenesis and Treatment of Immune-Mediated Kidney Disease: A Review. American Journal of Kidney Diseases, 79, 582-600.
https://doi.org/10.1053/j.ajkd.2021.07.019
|
[5]
|
Wada, Y., Matsumoto, K., Suzuki, T., Saito, T., Kanazawa, N., Tachibana, S., Iseri, K., Sugiyama, M., Iyoda, M. and Shibata, T. (2018) Clinical Significance of Serum and Mesangial Galactose-Deficient IgA1 in Patients with IgA Nephropathy. PLOS ONE, 13, e0206865. https://doi.org/10.1371/journal.pone.0206865
|
[6]
|
Placzek, W.J., Yanagawa, H., Makita, Y., Renfrow, M.B., Jul-ian, B.A., Rizk, D.V., Suzuki, Y., Novak, J. and Suzuki, H. (2018) Serum Galactose-Deficient-IgA1 and IgG Autoanti-bodies Correlate in Patients with IgA Nephropathy. PLOS ONE, 13, e0190967. https://doi.org/10.1371/journal.pone.0190967
|
[7]
|
Tan, L., Tang, Y., Pei, G.Q., Zhong, Z.X., Tan, J.X., Ma, Y., Wang, D.G., Zhou, L., Sheikh-Hamad, D. and Qin, W. (2021) Mesangial IgM Deposition Predicts Renal Outcome in Patients with IgA Nephropathy: A Multicenter, Observational Study. Clinical and Experimental Medicine, 21, 599-610. https://doi.org/10.1007/s10238-021-00703-1
|
[8]
|
Xiong, L., Liu, L., Tao, Y. and Guo, H. (2023) Clinical Signifi-cance of IgM and C3 Deposition in Children with Primary Immunoglobulin A Nephropathy. Journal of Nephrology. https://doi.org/10.1007/s40620-023-01724-7
|
[9]
|
Jiang, Y., Zan, J., Shi, S., Hou, W., Zhao, W., Zhong, X., Zhou, X., Lv, J. and Zhang, H. (2021) Glomerular C4d Deposition and Kidney Disease Progression in IgA Nephropathy: A Systematic Review and Meta-Analysis. Kidney Medicine, 3, 1014-1021. https://doi.org/10.1016/j.xkme.2021.06.009
|
[10]
|
Wu, D., Lei, L., Zhang, H., Yao, X., Chen, Z., Zhang, N., Ni, J., Ling, C., Liu, X. and Chen, X. (2023) Clinical Relevance of Glomerular C4d Deposition in Children with Early IgA Nephropathy or Henoch-Schönlein Purpura Nephropathy. Pediatric Nephrology, 38, 431-438. https://doi.org/10.1007/s00467-022-05585-3
|
[11]
|
Ramanathan, K. and Padmanabhan, G. (2020) MiRNAs as Po-tential Biomarker of Kidney Diseases: A Review. Cell Biochemistry & Function, 38, 990-1005. https://doi.org/10.1002/cbf.3555
|
[12]
|
Qin, W., Chung, A., Huang, X., Meng, X., Hui, D., Yu, C., Sung, J. and Lan, H. (2011) TGF-β/Smad3 Signaling Promotes Renal Fibrosis by Inhibiting miR-29. Journal of the American Society of Nephrology: JASN, 22, 1462-1474.
https://doi.org/10.1681/ASN.2010121308
|
[13]
|
Fang, Y., Yu, X., Liu, Y., Kriegel, A., Heng, Y., Xu, X., Liang, M. and Ding, X. (2013) miR-29c Is Downregulated in Renal Interstitial Fibrosis in Humans and Rats and Restored by HIF-α Activation. American Journal of Physiology. Renal Physiology, 304, F1274-F1282. https://doi.org/10.1152/ajprenal.00287.2012
|
[14]
|
Hennino, M., Buob, D., Van der Hauwaert, C., Gnemmi, V., Jomaa, Z., Pottier, N., Savary, G., Drumez, E., Noël, C., Cauffiez, C. and Glowacki, F. (2016) miR-21-5p Renal Expres-sion Is Associated with Fibrosis and Renal Survival in Patients with IgA Nephropathy. Scientific Reports, 6, Article No. 27209. https://doi.org/10.1038/srep27209
|
[15]
|
Fan, Q., Lu, R., Zhu, M., Yan, Y., Guo, X., Qian, Y., Zhang, L., Dai, H., Ni, Z. and Gu, L. (2019) Serum miR-192 Is Related to Tubulointerstitial Lesion and Short-Term Disease Pro-gression in IgA Nephropathy. Nephron, 142, 195-207.
https://doi.org/10.1159/000497488
|
[16]
|
Mizutani, K., Kawakami, K., Horie, K., Fujita, Y., Kameyama, K., Kato, T., Nakane, K., Tsuchiya, T., Yasuda, M., Masunaga, K., et al. (2019) Urinary Exosome as a Potential Biomarker for Uri-nary Tract Infection. Cellular Microbiology, 21, e13020. https://doi.org/10.1111/cmi.13020
|
[17]
|
Min, Q.H., Chen, X.M., Zou, Y.Q., Zhang, J., Li, J., Wang, Y., Li, S.Q., Gao, Q.F., Sun, F., Liu, J., et al. (2018) Differential Expression of Urinary Exosomal MicroRNAs in IgA Nephropathy. Journal of Clinical Laboratory Analysis, 32, e22226. https://doi.org/10.1002/jcla.22226
|
[18]
|
Feng, Y., Lv, L.L., Wu, W.J., Li, Z.L., Chen, J., Ni, H.F., Zhou, L.T., Tang, T.T., Wang, F.M., Wang, B., et al. (2018) Urinary Exosomes and Exosomal CCL2 mRNA as Biomarkers of Active Histologic Injury in IgA Nephropathy. The American Journal of Pathology, 188, 2542-2552. https://doi.org/10.1016/j.ajpath.2018.07.017
|
[19]
|
Li, S., Hao, H., Li, R. and Guo, S. (2022) Urinary Exosomal Mi-croRNAs as New Noninvasive Biomarkers of IgA Nephropathy. The Tohoku Journal of Experimental Medicine, 256, 215-223. https://doi.org/10.1620/tjem.256.215
|
[20]
|
Yamada, K., Huang, Z.Q., Raska, M., Reily, C., Anderson, J.C., Suzuki, H., Ueda, H., Moldoveanu, Z., Kiryluk, K., Suzuki, Y., et al. (2017) Inhibition of STAT3 Signaling Reduces IgA1 Autoantigen Production in IgA Nephropathy. Kidney International Reports, 2, 1194-1207. https://doi.org/10.1016/j.ekir.2017.07.002
|
[21]
|
Park, C.H., Han, D.S., Jeong, J.Y., Eun, C.S., Yoo, K.S., Jeon, Y.C. and Sohn, J.H. (2016) The Optimal Cut-Off Value of Neutrophil-to-Lymphocyte Ratio for Predicting Prognosis in Adult Patients with Henoch-Schönlein Purpura. PLOS ONE, 11, e0153238. https://doi.org/10.1371/journal.pone.0153238
|
[22]
|
Nagy, G.R., Kemény, L. and Bata-Csörgő, Z. (2017) Neutro-phil-to-Lymphocyte Ratio: A Biomarker for Predicting Systemic Involvement in Adult IgA Vasculitis Patients. Journal of the European Academy of Dermatology and Venereology, 31, 1033-1037. https://doi.org/10.1111/jdv.14176
|
[23]
|
Zhao, W.M., Tao, S.M. and Liu, G.L. (2020) Neutrophil-to-Lymphocyte Ratio in Relation to the Risk of All-Cause Mortality and Cardiovascular Events in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis. Renal Failure, 42, 1059-1066. https://doi.org/10.1080/0886022X.2020.1832521
|
[24]
|
Zhang, J., Zhang, R., Wang, Y., Wu, Y., Li, H., Han, Q., Guo, R., Wang, T., Wang, J., Grung, P. and Liu, F. (2019) Effects of Neutrophil-Lymphocyte Ratio on Renal Function and Histologic Lesions in Patients with Diabetic Nephropathy. Nephrology (Carlton), 24, 1115-1121. https://doi.org/10.1111/nep.13517
|
[25]
|
Shao, Y., Wu, B., Jia, W., Zhang, Z., Chen, Q. and Wang, D. (2020) Prognostic Value of Pretreatment Neutrophil-to- Lymphocyte Ratio in Renal Cell Carcinoma: A Systematic Review and Meta-Analysis. BMC Urology, 20, Article No. 90. https://doi.org/10.1186/s12894-020-00665-8
|
[26]
|
Ao, G., Wang, Y., Qi, X., Wang, F. and Wen, H. (2021) Association of Neutrophil-to-Lymphocyte Ratio and Risk of Cardio-vascular or All-Cause Mortality in Chronic Kidney Disease: A Meta-Analysis. Clinical and Experimental Nephrology, 25, 157-165. https://doi.org/10.1007/s10157-020-01975-9
|
[27]
|
Simonaggio, A., Elaidi, R., Fournier, L., Fabre, E., Ferrari, V., Borchiellini, D., Thouvenin, J., Barthelemy, P., Thibault, C., Tartour, E., et al. (2020) Variation in Neutrophil to Lymphocyte Ratio (NLR) as Predictor of Outcomes in Metastatic Renal Cell Carcinoma (mRCC) and Non-Small Cell Lung Cancer (mNSCLC) Patients Treated with Nivolumab. Cancer Immunology, Immunotherapy, 69, 2513-2522. https://doi.org/10.1007/s00262-020-02637-1
|
[28]
|
Wang, S., Dong, L., Pei, G., Jiang, Z., Qin, A., Tan, J., Tang, Y. and Qin, W. (2021) High Neutrophil-to-Lymphocyte Ratio Is an Independent Risk Factor for End Stage Renal Diseases in IgA Nephropathy. Frontiers in Immunology, 12, Article ID: 700224. https://doi.org/10.3389/fimmu.2021.700224
|
[29]
|
Li, Q., Chen, P., Shi, S., Liu, L., Lv, J., Zhu, L. and Zhang, H. (2020) Neutrophil-to-Lymphocyte Ratio as an Independent Inflammatory Indicator of Poor Prognosis in IgA Nephropa-thy. International Immunopharmacology, 87, Article ID: 106811. https://doi.org/10.1016/j.intimp.2020.106811
|
[30]
|
Holinstat, M. (2017) Normal Platelet Function. Cancer and Me-tastasis Reviews, 36, 195-198.
https://doi.org/10.1007/s10555-017-9677-x
|
[31]
|
Kumarasamy, C., Tiwary, V., Sunil, K., Suresh, D., Shetty, S., Muthukaliannan, G.K., Baxi, S. and Jayaraj, R. (2021) Prognostic Utility of Platelet-Lymphocyte Ratio, Neutro-phil-Lymphocyte Ratio and Monocyte-Lymphocyte Ratio in Head and Neck Cancers: A Detailed PRISMA Compliant Systematic Review and Meta-Analysis. Cancers (Basel), 13, Article No. 4166. https://doi.org/10.3390/cancers13164166
|
[32]
|
Li, L., Yu, J. and Zhou, Z. (2021) Platelet-Associated Parameters in Patients with Psoriasis: A PRISMA-Compliant Systematic Review and Meta-Analysis. Medicine (Baltimore), 100, e28234.
https://doi.org/10.1097/MD.0000000000028234
|
[33]
|
Li, L.Q., Bai, Z.H., Zhang, L.H., Zhang, Y., Lu, X.C., Zhang, Y., Liu, Y.K., Wen, J. and Li, J.Z. (2020) Meta-Analysis of Hematological Biomarkers as Reliable Indicators of Soft Tissue Sarcoma Prognosis. Frontiers in Oncology, 10, Article No. 30. https://doi.org/10.3389/fonc.2020.00030
|
[34]
|
Chang, D., Cheng, Y., Luo, R., Zhang, C., Zuo, M., Xu, Y., Dai, W., Li, Y., Han, M., He, X., et al. (2021) The Prognostic Value of Platelet-to-Lymphocyte Ratio on the Long-Term Renal Survival in Patients with IgA Nephropathy. International Urology and Nephrology, 53, 523-530. https://doi.org/10.1007/s11255-020-02651-3
|
[35]
|
Tan, J., Song, G., Wang, S., Dong, L., Liu, X., Jiang, Z., Qin, A., Tang, Y. and Qin, W. (2022) Platelet-to-Albumin Ratio: A Novel IgA Nephropathy Prognosis Predictor. Frontiers in Immunology, 13, Article ID: 842362.
https://doi.org/10.3389/fimmu.2022.842362
|